Both in Pharmaceuticals
Whitehawk Therapeutics vs Akebia Therapeutics
Over the past year WHWK returned +35.0% and AKBA returned −68.0%; their daily moves had a correlation of 0.11.
WHWK +35.0% AKBA −68.0%Growth of $1, one year, split-adjusted
| Metric | WHWK | AKBA |
|---|---|---|
| Price | $3.24 | $0.7065 |
| Market cap | $184.7M | $195.8M |
| Today | −1.82% | −4.81% |
| 1 month | −13.8% | −18.9% |
| 6 months | −18.8% | −49.5% |
| Year to date | +33.9% | −56.1% |
| 1 year | +31.7% | −66.4% |
| Revenue growth (YoY) | — | −21.4% |
| Gross margin | — | 78.8% |
| Net margin | — | −18.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $190.0M | $106.0M |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | 73.8% |
| Short % of float | 8.7% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).